Tidemark’s Integra LifeSciences IART Stock Holding History

Tidemark’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$414	Hold	44	–	–	﹤0.01%	784
2025 Q4	$546	Hold	44	–	–	﹤0.01%	622
2025 Q3	$631	Hold	44	–	–	﹤0.01%	654
2025 Q2	$540	Hold	44	–	–	﹤0.01%	670
2025 Q1	$968	Buy	+44	New	+$1.03K	﹤0.01%	650
2024 Q4	–	Sell	-44	Closed	-$799	–	650
2024 Q3	$799	Hold	44	–	–	﹤0.01%	582
2024 Q2	$1.28K	Hold	44	–	–	﹤0.01%	549
2024 Q1	$1.56K	Hold	44	–	–	﹤0.01%	614
2023 Q4	$1.92K	Buy	+44	New	+$1.73K	﹤0.01%	597

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tidemark's IART Position: Q1 2026 in Review

Tidemark held its Integra LifeSciences (IART) position steady in Q1 2026 at 44 shares worth $414. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Tidemark first reported a position in IART in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.92K in Q4 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Tidemark held 44 shares of Integra LifeSciences worth $414 as of Q1 2026.
Tidemark left its Integra LifeSciences share count unchanged in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Tidemark's portfolio in Q1 2026, its #784 holding.
Tidemark first reported a position in Integra LifeSciences in Q4 2023 and has held it in 9 quarters since.
Tidemark's Integra LifeSciences position peaked at $1.92K in Q4 2023.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.